Picture of Eureking SA logo

KINGS Eureking SA Share Price

0.000.00%
fr flag iconLast trade - 00:00
FinancialsAdventurousMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-5.34%
3m+1.07%
6m+1.41%
1yr+1.47%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-2.49%
Return on Equity-5.04%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202331st Mar 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Eureking SA EPS forecast chart

Profile Summary

Eureking SA is a France-based special purpose acquisition company (SPAC) formed with the aim of acquiring targets companies in the field of pharmaceutical industry. The Company intends to the European and fast-growing companies specializing in three business segments: the production of biological products, cell and gene therapies and live Biotherapeutics (with applications in the microbiome). The Biotherapies and technological solutions in the Biopharmaceutical companies are used to develop new treatments with both logistical and industrial support along with the tools and production capacity to pursue the clinical developments or to market the products.

Directors

    Last Annual
    March 31st, 2022
    Last Interim
    June 30th, 2023
    Incorporated
    March 16th, 2022
    Public Since
    May 12th, 2022
    Sector
    Holding Companies
    Industry
    Financials
    Exchange
    fr flag iconEuronext - Paris
    Shares in Issue
    5,000,000
    Blurred out image of a map
    Address
    128 Rue De La Boetie, PARIS, 75008
    Web
    https://eureking.com/
    Phone
    Auditors
    Ernst & Young Audit

    KINGS Share Price Performance

    Upcoming Events for KINGS

    Eureking SA Extraordinary Shareholders Meeting

    Similar to KINGS

    Picture of Burelle SA logo

    Burelle SA

    fr flag iconEuronext - Paris

    Picture of Idsud SA logo

    Idsud SA

    fr flag iconEuronext - Paris

    Picture of NR 21 SA logo

    NR 21 SA

    fr flag iconEuronext - Paris

    Picture of Selcodis SA logo

    Selcodis SA

    fr flag iconEuronext - Paris

    FAQ